Posted inBusiness
Dr. Reddy’s Biologics Facility Faces Fresh FDA Scrutiny with Seven Observations
The U.S. Food and Drug Administration (FDA) recently issued a Form 483 with seven observations to Dr. Reddy's Laboratories' biologics manufacturing facility in Hyderabad, India, following a routine inspection, signaling…
